Join geneticist Kevin Folta and guest host Ally Kennedy on this episode of Science Facts and Fallacies as they break down these latest news stories:
We’ve learned a lot about SARS-COV-2 over the last 19 months, and one of our best resources has been the genome of the virus itself. By sequencing the microbe’s genetic makeup and then continually tweaking in the lab, scientists have developed diagnostic tests, vaccines and a handful of treatments for COVID-19. Many scientists now believe this kind of work will be key to taking on pandemics of the future.
While COVID-19 has regrettably claimed millions of lives, it may have also incentivized the kind of research that will allow us to knock out other deadly viruses before they can take similarly destructive tolls.
For many years, scientists drew an ethical boundary between somatic-cell gene editing and germline gene editing, which passes on changes in DNA to the next generation. The former, scientists generally agreed, was a revolutionary way to tackle deadly diseases without playing God; the latter enabled us to literally genetically engineer humans in a lab and was thus out of bounds.
But the situation is changing as gene-editing technology evolves and regulators around the world attempt to flesh out guidelines to ensure the safe, responsible use of germline editing. Are we jeopardizing the future of humanity by experimenting with such powerful tools, or is it necessary to harness the technology to prevent its misuse?
The plasmodium form of Physarum polycephalum–dubbed “the blob” by researchers who study it–has no brain, central nervous system or even specialized tissues—yet it can solve complex problems and remember novel substances it encounters. As a result, this odd, little plasmodium is changing how we study cognition. How much do we know about the blob, and might it help us solve some of humanity’s lingering problems?
Kevin M. Folta is a professor in the Horticultural Sciences Department at the University of Florida. Follow Professor Folta on Twitter @kevinfolta
Ally Kennedy is a premedical student at the University of Florida. She has a particular interest in infectious disease, pain neurology—and more recently, COVID-19. Visit her website and follow her on Twitter @AllyAnswers